Consultant medical oncologist and medical director for Cancer and Surgery Clinical Group
Dr Rigg trained in London and completed her specialist training as a medical oncologist at the Royal Marsden Hospital. She has been a consultant at Guy’s and St Thomas’ Hospitals since 2005. Dr Rigg specialises in the systemic anti-cancer therapies for breast cancer, with an interest in interventional clinical trials and the importance of real world evidence to drive service improvement and generate research hypotheses.
Dr Rigg is a clinical leader and has held a number of roles within Guy’s and St Thomas’ including clinical director for oncology. She is also currently the medical director for the Cancer and Surgery Clinical Group. She is involved in the development of the clinical leaders of the future.
She is the NHS England Chair of the Chemotherapy Clinical Reference Group. She represents medical oncology at the Royal College of Physicians Patient Safety Committee and sits on the steering committees of the UK Chemotherapy Board, Association of Physicians and Intercollegiate Committee of Haematology.
Education and training
1989 Intercalated BSc Psychology
1991 MBBS University of London
2000 PhD Imperial College
Medical Oncology specialist training, Royal Marsden Hospital, London
- phase 3 clinical trial in breast cancer
- real world evidence in cancer
- health inequalities for cancer patients
- fellowship of the Royal College of Physicians UK
British Menopause Society consensus statement on the management of estrogen deficiency symptoms, arthralgia and menopause diagnosis in women treated for early breast cancer. Marsden et al 2019
Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer. Dodson et al Breast Cancer Research 2017
The impact of OncotypeDX breast cancer assay results on clinical practice –a UK experienceVE. Crolley et al UKBCG 2016
- Venous thrombosis rates in early breast cancer patients receiving FEC chemotherapy: a retrospective analysis. ECCO 2011
- A diagnosis of cancer in people with severe mental illness: practical and ethical issues raised. Howard et al Lancet Oncology 2010.
Dr Rigg has an interest in the utilisation of real world data to address important clinical questions and is Co-Chair of the Guy’s Cancer Real World Evidence Committee with Prof Van Hemelrijck. This consortium published extensively during the COVID-19 pandemic and contributed to the national understanding of the impact of COVID-19 for cancer patients.
Dr Rigg has been and continues to be principal investigator for breast cancer clinical trials.
Last updated: April 2022